- 掃描二維碼關(guān)注儀器無憂網(wǎng)微信公眾平臺
- 您可以獲得:
- 1.更高效的咨詢方式
- 2.更便利的瀏覽體驗
- 3.實時的動態(tài)信息獲取
- 儀器無憂網(wǎng)
- 服務(wù)中心
牛津基因技術(shù)
OGT
英國牛津基因科技公司(簡稱OGT)(Oxford Gene Technology) www.ogt.co.uk
牛津基因技術(shù)公司(Oxford Gene Technology,OGT)1995年,主要進(jìn)行高通量的核酸分析工作。除了進(jìn)行基因組研究外,還包括核酸雜交等的基礎(chǔ)研究,如研究核酸單鏈結(jié)構(gòu)對雜交過程中雙鏈形成的影響。薩瑟恩的研究小組還改進(jìn)了反義核酸試劑使其效果更加理想,開發(fā)新的基因剔除試劑從而在細(xì)胞內(nèi)基因操作方面得到廣泛應(yīng)用。
Founded in 1995 by the pioneer of Southern Blotting and microarray technologies, Professor Sir Edwin Southern, OGT is based in Oxford, UK.
OGT's management team brings a unique combination of world-recognised science, combined with a strong track record in licensing intellectual property, product development and commercialisation of technology
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir Edwin Southern, OGT operates out of Begbroke Business Park near Oxford, with excellent access to a growing network of life science companies
· OGT offers a comprehensive custom microarray consultancy service, from experimental design through all stages to data analysis and interpretation. It has a strong proven track record in providing custom microarray service in a range of applications, and in May 2006 announced the launch of its first microarray product, an Escherichia coli K12 ChIP on chip, the first ChIP microarray product to be launched as part of OGT’s Prokaryotic Chip2 family
The key focus areas of OGT include:
1. Array-based application products and services for life science research and molecular diagnostics. OGT’s flexible and cost-effective, customised DNA microarray service covers a range of applications, offering specialist support and assisting customers with every aspect of their research, from initial consultation and experimental design to probe selection, array design and fabrication through to data analysis and interpretation.
2. Development of innovative platform products for clinical research and diagnostics
3. Licensing. OGT operates an open licensing policy which has successfully provided access for a number of companies to OGT's fundamental intellectual property, particularly in the area of microarrays